ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
ESC Premium Access
Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial.
Session:
Meet the Trialists - HPS3/TIMI55-REVEAL
Topic:
Lipids (Epidemiology and Prevention)
Speaker:
Professor M. Landray (Oxford, GB)
Event:
ESC Congress 2017
Congress Presentation
Sign in for access options
Sign in for access options
Add to my library
Like
About the speaker
Professor Martin Landray
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
7
presentations
0
follower
Access the full session
Meet the Trialists - HPS3/TIMI55-REVEAL
Speakers:
Professor M. Landray
Access
Like
About the event
ESC Congress 2017
26 August - 30 August 2017
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources
Explore sponsored resources